Partnership Expansion
Evonik and AMSilk have extended their collaboration with a long-term agreement to produce sustainable silk proteins at an industrial scale. This builds on their initial 2023 agreement, with a new manufacturing line commissioned at Evonik’s Slovakian site.
Production Capabilities
The dedicated production line at Evonik’s biotech hub in Slovakia is equipped with advanced infrastructure and renewable energy. It ensures a consistent monthly output of several tons of AMSilk’s high-performance silk proteins, tailored to meet certified industrial quality standards.
Market Potential
AMSilk transforms the silk protein powder into high-performance yarns, offering premium quality and regulatory compliance. The company targets a €16 billion serviceable market within the €26 billion total protein fiber market, which includes silk, cashmere, and merino.
Sustainability Focus
AMSilk’s biomaterials are vegan, biodegradable, and derived from renewable plant-based carbon, leaving no microplastics at the end of their lifecycle. The collaboration reflects a shared belief in biotechnology’s potential to provide sustainable alternatives to fossil-based products.
